CIBC Private Wealth Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

CIBC Private Wealth Group’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-214	Closed	-$20K	–	949
2019 Q2	$20K	Hold	214	–	–	﹤0.01%	909
2019 Q1	$32K	Hold	214	–	–	﹤0.01%	916
2018 Q4	$34K	Hold	214	–	–	﹤0.01%	858
2018 Q3	$53K	Buy	214 +57	+36%	+$13.5K	﹤0.01%	950
2018 Q2	$35K	Buy	157 +71	+83%	+$19K	﹤0.01%	1254
2018 Q1	$21K	Sell	86 -43	-33%	-$11.3K	﹤0.01%	1381
2017 Q4	$40K	Buy	+129	New	+$42.4K	﹤0.01%	1238

Other funds holding DMK

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

CIBC Private Wealth Group's DMK Position: Q3 2019 in Review

CIBC Private Wealth Group sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2019, closing a stake of 214 shares — an estimated $20K sold.

CIBC Private Wealth Group first reported a position in DMK in Q4 2017 and held it in 7 quarters. The position peaked at $53K in Q3 2018. 50 funds tracked by Wall St. Rank hold DMK as of Q3 2019.

CIBC Private Wealth Group reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2019 after selling out during the quarter.
CIBC Private Wealth Group sold 214 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2019, an estimated $20K.
CIBC Private Wealth Group first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2017 and held it in 7 quarters.
CIBC Private Wealth Group's DMK Pharmaceuticals Corporation Common Stock position peaked at $53K in Q3 2018.
50 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2019.

Based on CIBC Private Wealth Group's 13F filing for Q3 2019, filed 16 Oct 2019.